The future of best investing in vaccines: the Health Technology Assessment approach

Vaccine. 2008 Mar 20;26(13):1609-10. doi: 10.1016/j.vaccine.2008.01.009. Epub 2008 Feb 1.

Abstract

Over the past two decades, scientific research has led to the development of a huge number of new health technologies, among which new vaccines. The decision process underlying the introduction of a new vaccine will be of particular concern in the future and a useful tool is needed to orientate decision makers towards better allocation of economic resources. Health Technology Assessment (HTA) is a multidisciplinary tool that aims to examine the clinical, economic, organizational, ethical, juridical, social and cultural implications of the introduction or the implementation of a specific technology; it could so represent an innovative and effective approach in order to support decision-making processes.

MeSH terms

  • Biomedical Technology / economics*
  • Biomedical Technology / trends*
  • Drug Industry / economics*
  • Drug Industry / trends*
  • Health Care Costs
  • Health Expenditures
  • Humans
  • Infection Control / economics
  • Infection Control / trends
  • Vaccines / economics*

Substances

  • Vaccines